Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 8/20 | 0.67 |
| ▸ | RARB | P10826 | 4/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | THRA | P10827 | 6/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.45 |
| ▸ | RELA | Q04206 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13446673 | 1.00 | THRB (0.67) | THRBRARBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL75102 | 1.00 | THRB (0.67) | THRBRARBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL815928 | 0.99 | THRB (0.69) | THRBRARBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL14571749 | 0.86 | THRB (0.54) | THRBRARBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL16425791 | 0.86 | MAPT (0.53) | THRBRARBSMN1; SMN2MAPTMEN1 | |
| SCHEMBL9817695 | 0.85 | RARB (0.70) | THRBRARBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL9817321 | 0.85 | RARB (0.70) | THRBRARBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL9817470 | 0.85 | RARB (0.70) | THRBRARBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL9817442 | 0.85 | RARB (0.70) | THRBRARBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL9817342 | 0.85 | RARB (0.70) | THRBRARBSMN1; SMN2MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8139189-B2 | Liquid crystal display having particular oblique vapor deposition-alignment layer with ferroelectric liquid crystal | DAI NIPPON PRINTING CO., LTD. (JP) | 2012-03-20 | — | — | US | disclosed |
| US-8130358-B2 | Liquid crystal display | DAI NIPPON PRINTING CO., LTD. (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8009266-B2 | Process for producing liquid crystal display | DAI NIPPON PRINTING CO., LTD. (JP) | 2011-08-30 | — | — | US | disclosed |
| US-7892449-B2 | Liquid crystal display and manufacturing method of same | DAI NIPPON PRINTING CO., LTD. (JP) | 2011-02-22 | — | — | US | disclosed |
| US-7871540-B2 | Polymerizable liquid crystal composition | DIC CORPORATION (JP) | 2011-01-18 | — | — | US | disclosed |
| US-7777847-B2 | Liquid crystal display and manufacturing method of the same | DAI NIPPON PRINTING CO., LTD. (JP) | 2010-08-17 | — | — | US | disclosed |
| US-20100060844-A1 | PROCESS FOR PRODUCING LIQUID CRYSTAL DISPLAY | DAI NIPPON PRINTING CO., LTD. (JP) | 2010-03-11 | — | — | US | disclosed |
| US-20100053525-A1 | LIQUID CRYSTAL DISPLAY | DAI NIPPON PRINTING CO., LTD. (JP) | 2010-03-04 | — | — | US | disclosed |
| US-20100007832-A1 | LIQUID CRYSTAL DISPLAY | DAI NIPPON PRINTING CO., LTD. (JP) | 2010-01-14 | — | — | US | disclosed |
| US-7570331-B2 | Liquid crystal display | DAI NIPPON PRINTING CO., LTD. (JP) | 2009-08-04 | — | — | US | disclosed |
| US-7499135-B2 | Liquid crystal display | DAI NIPPON PRINTING CO., LTD. (JP) | 2009-03-03 | — | — | US | disclosed |
| US-20090050844-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION | DIC CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20070026165-A1 | Liquid crystal display and manufacturing method of same | DAI NIPPON PRINTING CO., LTD. (JP) | 2007-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090050844-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION | H1-0, H1-4, H1-10 | THRB 3657/4885RARB 3123/4885SMN1; SMN2 4185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.